CORRECTION: Enlivex Therapeutics Q4 Adj. EPS $(0.20) Misses $(0.01) Estimate. Adj EPS Excludes Change In Fair Value Of Digital Assets Purchase Option

Benzinga Newsdesk www.benzinga.com Neutral 85.8%